Enhancing Access to Lung Cancer Screening with Emphasis on Health Disparities: Insights from Professionals in the UK NHS Lung Cancer Screening Initiative - Top-Institutions - MDSpire

Enhancing Access to Lung Cancer Screening with Emphasis on Health Disparities: Insights from Professionals in the UK NHS Lung Cancer Screening Initiative

  • By

  • Arbaz Kapadi

  • Gemma Howard

  • Zoe Merchant

  • Philip A J Crosbie

  • David P French

  • Lorna McWilliams

  • March 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Manchester
    University of Manchester

    Manchester, England

    Key Differentiators

    • Oncology
    • Public Health
    • Radiology
    • Health Disparities

  • #2

    University College London (UCL)
    University College London (UCL)

    London, England

    Key Differentiators

    • Oncology
    • Radiology
    • Epidemiology
    • Health Services Research

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Radiology
    • Cancer Screening
    • Health Disparities

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Public Health
    • Radiology
    • Health Equity

  • #5

    University of Toronto
    University of Toronto

    Toronto, Ontario

    Key Differentiators

    • Oncology
    • Radiology
    • Population Health
    • Health Disparities

Original Source(s)

Enhancing Access to Lung Cancer Screening with Emphasis on Health Disparities: Insights from Professionals in the UK NHS Lung Cancer Screening Initiative

  • by Arbaz Kapadi, Gemma Howard, Zoe Merchant, Philip A J Crosbie, David P French, Lorna McWilliams

  • March 9, 2026

Related Content

HHLA2 as an emerging immune checkpoint in lung cancer: linking EGFR signaling, macrophage polarization, and CD8+ T-cell metabolic suppression

An ASCO preview: What to watch for at cancer research’s big meeting

Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report